Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Advanced Solid Tumor × ulixertinib × 1 year × Clear all

Sponsor

Conditions

Glioma 3 Wilms Tumor 2 Sarcoma, Ewing 2 Sarcoma 2 Rhabdomyosarcoma 2 Rhabdoid Tumor 2 Pancreatic Neoplasms 2 Osteosarcoma 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neuroblastoma 2 Neoplasms 2 Melanoma 2 Medulloblastoma 2 Lymphoma, Non-Hodgkin 2 Histiocytosis, Langerhans-Cell 2 Hepatoblastoma 2 Ependymoma 2 Colorectal Neoplasms 2 Xanthogranuloma, Juvenile 1 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Ovarian Neoplasms 1 Histiocytic Sarcoma 1 Histiocytic Neoplasms 1 Head and Neck Neoplasms 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Esophageal Neoplasms 1

Interventions

Injections 11 tislelizumab 9 pembrolizumab 7 toripalimab 5 atezolizumab 4 Paclitaxel 4 Carboplatin 4 Bevacizumab 4 Oxaliplatin 3 Nivolumab 3 Fluorouracil 3 olaparib 2 niraparib 2 lenvatinib 2 Pemetrexed 2 Leucovorin 2 Gemcitabine 2 Docetaxel 2 Cyclophosphamide 2 Cisplatin 2 Cetuximab 2 zimberelimab 1 trastuzumab deruxtecan 1 talazoparib 1 spartalizumab 1 sintilimab 1 serabelisib 1 penpulimab 1 nedaplatin 1 fludarabine phosphate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡